Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aridis Pharmaceuticals Inc (ARDS)

Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aridis Pharmaceuticals Inc 983 University Avenue Bldg. B Los Gatos CA 95032 USA

www.aridispharma.com P: 408-385-1742

Description:

Aridis Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the discovery and development of immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. The company's product pipeline consists of AR-301, AR-105, AR-101, AR-401, AR-201 and AR-501 which are in clinical stages. Aridis Pharmaceuticals, Inc. is based in San Jose, United States.

Key Statistics

Overview:

Market Capitalization, $K 5
Enterprise Value, $K -5,055
Shares Outstanding, K 53,321
Annual Sales, $ 3,090 K
Annual Net Income, $ -30,370 K
Last Quarter Sales, $ 420 K
Last Quarter Net Income, $ -80 K
EBIT, $ -880 K
EBITDA, $ -390 K
60-Month Beta 0.87
% of Insider Shareholders 5.50%
% of Institutional Shareholders 9.65%
Float, K 50,388
% Float 94.50%
Short Volume Ratio 0.06

Growth:

1-Year Return -99.88%
3-Year Return -100.00%
5-Year Return -100.00%
5-Year Revenue Growth 259.30%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 12/09/24 [--]
Earnings Per Share ttm -0.18
EPS Growth vs. Prev Qtr -106.06%
EPS Growth vs. Prev Year 95.24%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ARDS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -982.85%
Debt/Equity 0.00
Price/Sales 0.00
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.26
Interest Coverage -3.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar